Introduction
============

Scientific and clinical background
----------------------------------

Depressive disorder is a public health priority: It was estimated to be the 15th leading cause of global disability adjusted life years (DALYs) as of 2015, an increase from the 19th leading cause in 1990 ([@ref-13]). Depressive disorder was also the second leading cause of years lived with disability (YLDs) in 2010, accounting for an estimated 8.2% of all YLDs ([@ref-6]). Depression is one of the most prevalent, yet unrecognized but treatable mental disorders in low and middle income countries (LMICs); easy to administer, valid and reliable screening tools that can assist in detecting depression will be useful in both clinical care and research in geographic areas with limited access to psychiatric professionals.

One of the most widely used screening tools for depressive disorder is the Patient Health Questionnaire (PHQ-9) ([@ref-18]). The PHQ-9 was originally developed by Spitzer and colleagues in the mid-1990s, as part of the Primary Care Evaluation of Mental Disorders (PRIME-MD), a diagnostic tool containing modules on 12 different mental health disorders. The PHQ-9 is a tool specific for screening for depressive symptoms, within the mood module of the original PRIME-MD ([@ref-14]; [@ref-32]; [@ref-34]).

The PHQ-9 is based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria of depressive disorder and has nine items with a score ranging from 0 to 3 for each item (0 = not at all, 1 = several days, 2 = more than half days, 3 = almost every day of a two-week recall period). The total score ranges from 0 to 27. Using standard cutoffs, a score of 5--9 indicates mild severity of major depression, 10--14 indicates moderate severity, 15--19 indicates moderately severe depression, while 20 or higher indicates severe major depression ([@ref-14]). The 10 point cut-off is most commonly used to indicate symptoms having reached clinically significant levels requiring full diagnostic assessment ([@ref-17]). For this study, we generate a continuous total score as well as grade the depressive symptoms using a range of cutoffs.

Over the years, the PHQ-9 has been validated in many settings and has shown to have good sensitivity and specificity when compared to diagnostic interviews ([@ref-18]; [@ref-22]). The PHQ-9 has also been translated into myriad languages, with many translations validated ([@ref-1]; [@ref-3]; [@ref-11]; [@ref-12]; [@ref-16]; [@ref-43]). A number of recent studies on its validity and internal reliability, for screening for depression, and in monitoring treatment response have been published ([@ref-4]; [@ref-15]; [@ref-21]; [@ref-39]; [@ref-41]). As noted above, a score of ≥10 on PHQ-9 has been recommended for use as a diagnostic cut-off for possible major depressive disorder ([@ref-14]), although more recently researchers have recommended less strict adherence to any single cut-off ([@ref-17]). A recent meta-analysis of 36 studies conducted in a range of settings but mainly in high-income countries found that the PHQ-9 cut-off of 10 had 78% (95% confidence interval \[CI\]: 70%--84%) sensitivity and 87% (95% CI \[84%--90%\]) specificity for detecting major depressive disorder in primary care and hospital settings ([@ref-22]), when compared against a "gold standard" such as the structured clinical interview for DSM disorders (SCID).

In Pakistan, the Urdu version PHQ-9 has been used in hospital and community settings as a screening tool for depressive disorder ([@ref-8]; [@ref-9]). Although criterion-related validity of an Urdu version of the PHQ-9 has been tested against the validated Urdu version Self Reporting Questionnaire (SRQ) among patients with coronary artery disease in an urban setting in Pakistan ([@ref-9]), the PHQ-9 has not been tested for criterion-related validity in a rural setting nor among pregnant or perinatal (that is, including a number of weeks after birth) women in Pakistan. Pregnancy or the entire perinatal period is an especially vulnerable period for women to develop mood disorders, and Pakistan has a very high burden of perinatal depression ([@ref-7]; [@ref-27]; [@ref-30]). Therefore, having a valid screening tool is useful not only to assist in case identification but also, if compared to a diagnostic criterion tool, for impact evaluation of psychosocial interventions in this population.

There is debate around whether and when to screen adults for depression in primary care settings ([@ref-37]; [@ref-38]). The United States Preventive Services task force recommends screening only when adequate resources exist to manage the condition, while the UK and Canadian task forces recommend against it ([@ref-38]). There is even less information on the appropriateness of screening in perinatal populations ([@ref-35]). However, much of this research has focused on high income countries. In rural areas of LMICs where mental health services are virtually non-existent (such as in rural Pakistan), no clear recommendations exist. Benefits and drawbacks of screening for depressive disorder must be weighed considering the health resources that do exist and the negative consequences associated with leaving populations undiagnosed in which the prevalence of depression is estimated to be about 25% ([@ref-27]; [@ref-30]).

The current study aimed at demonstrating the criterion-related validity and internal reliability of the Urdu version of the PHQ-9 in a sample of community-based pregnant women in Pakistan compared to a diagnostic clinical interview, the Structured Clinical Interview for DSM disorders (SCID) ([@ref-33]). The major depressive episode section of the SCID has previously been translated into Urdu and culturally adapted ([@ref-28]), and has been extensively used cross-culturally in studies of depression among pregnant women ([@ref-10]; [@ref-24]). The primary goal of this study is to determine if the Urdu version of the PHQ-9 provides an adequate tool for testing for depressive symptoms among pregnant women in rural settings in Pakistan by examining its internal reliability and its criterion-related validity relative to the SCID. Ethical approval for this study was obtained for this study from both U.S.-based (Duke University) and Pakistan-based (Human Development Research Foundation) institutional review boards (IRBs). In reporting the results of this study, we followed the Standards for Reporting of Diagnostic Accuracy Studies (STARD) 2015 guidelines ([@ref-5]).

Materials & Methods
===================

Study design and setting
------------------------

The current study is part of the Thinking Healthy Programme Peer-Delivered (THPP) and Thinking Healthy Programme Peer-Delivered Plus (THPP+) cluster randomized trials (Duke University IRB approval \#Pro00047609; Human Development Research Foundation IRB approval \#IRB/2014/002 and \#IRB/003/2016) ([@ref-31]; [@ref-40]). The trials were conducted in the sub-district Kallar Syedan, Rawalpindi District, Pakistan. The sub-district has a population of about 200,000, and is representative of a typical low-socioeconomic rural area of Potohar Plateau situated in the north of the Punjab Province of Pakistan. Most families depend on subsistence farming, supported by earnings of one or more adult male members serving in the armed forces, or working as government employees, semi-skilled, or unskilled laborers in the nearby cities. The spoken and written language in the study area is Urdu. Male and female literacy rates are approximately 64% and 40%, respectively, in rural Punjab province according to the report from the most recent Demographics and Health Survey ([@ref-25]). Mental health services are virtually non-existent in the sub-district.

The aim of these trials is to test the effect on perinatal depression of an extended and peer-delivered version of a previously successful intervention ([@ref-29]). All pregnant women, registered with community health workers (called Lady Health Workers) of the sub-district Kallar Syedan, Rawalpindi District, Pakistan, were approached by study personnel and, after providing written (or witnessed, if illiterate) informed consent, screened for depression using the Urdu version of the PHQ-9. Following the PHQ-9, the diagnostic module for current major depressive episode of the Structured Clinical Interview for DSM disorders (SCID) was administered by the same assessor within the same interview ([@ref-33]).

The study was conducted from October 2014 to February 2016, coinciding with screening and baseline data collection for the THPP and THPP+ trials ([@ref-31]; [@ref-40]). All interviews were administered by study personnel at the households of the participants or at the house of the Lady Health Worker, whichever was more convenient for the pregnant women. The details of the trials and the recruitment criteria of its community-based depressed and non-depressed pregnant women can be found in the respective protocol papers ([@ref-31]; [@ref-40]). In brief, to be eligible for screening, women must be married, in their third trimester of pregnancy, 18 years of age or older, and intend to remain in the study area for at least 1 year. Women are ineligible if they do not speak one of the study languages (Urdu, Punjabi or Potohari) or if they require immediate inpatient care for any reason. Target sample size for the THPP+ trial was determined based on the estimated effect size of the primary outcome between intervention and control arms at 36 months ([@ref-40]).

In total, 1,910 pregnant women across the sub-district were approached for consent and screening for depressive symptoms; 25 (1.3%) women refused screening while 154 (8.1%) were ineligible for enrollment. Of those ineligible, 110 (71.4%) were women in their 1st or 2nd trimester of pregnancy, eight (5.2%) were younger than 18 years old and not able to provide consent, 11 (7.1%) did not intend to remain in the study area, 22 (14.3%) did not speak one of the study languages, and three (1.9%) required immediate inpatient care. Thus, 1,731 community-based pregnant women in their 3rd trimester of pregnancy were screened for current major depressive episode using the Urdu version PHQ-9, which was followed by the SCID diagnostic tool during the same interview. Of these, 1,154 were retained for the baseline sample of THPP+ because of the sampling design, for which the goal was to recruit into the study every woman who was considered depressed (PHQ-9 ≥ 10), and approximately one out of every three non-depressed (PHQ-9 \< 10) women screened, based on the estimated prevalence of depression in the population ([@ref-31]; [@ref-40]). Criterion-related validity and internal reliability of the PHQ-9 were estimated in the full screening sample (*n* = 1, 731). All members of the research team conducting the interviews had a master's degree in either psychology or behavioral sciences, and all of the team members had extensive experience of administering diagnostic interviews for depression within the same study area ([@ref-20]; [@ref-40]). They were also supervised weekly by a trained and experienced psychiatrist.

Test methods
------------

The translated Urdu version of the PHQ-9 was used as the index test ([@ref-23]). Prior to its use, some difficult Urdu words were replaced by simpler and more frequently used words carrying the same meaning. This was done to help address any potential issue of comprehensibility when administered in a low literacy rural population. For example, a difficult and not commonly used Urdu word for "feeling down" was changed to an easier Urdu word with the same meaning. This was done by a panel of mental health experts with extensive clinical and field experience of working in low literacy populations. Comprehensibility was examined by pilot testing the PHQ-9 among 250 pregnant women prior to the start to the study. These women were also asked if any of the items were not understood. None of these 250 women were part of the trial screening sample, and no adjustments were made to the index test as a result of the pilot testing.

The translated Urdu version of the major depressive episode section of the SCID was used as the reference standard. The SCID was chosen as the reference standard because the Urdu version of this tool was previously translated and culturally adapted for a prior study in this region using a rigorous procedure ([@ref-28]; [@ref-29]). The SCID is a semi-structured interview that generates case vs non-case diagnosis of current major depressive episode by inquiring about the individual symptoms of depression. To make a diagnosis of depression at least five symptoms are needed, including depressed mood or loss of interest ([@ref-33]). The Urdu and English version of both the index and reference test are included as a [Supplementary File](#supplemental-information){ref-type="supplementary-material"}.

As previously mentioned, a cutoff of 10 or above on the PHQ-9 was used to identify women with sufficient depressive symptoms to indicate a high probability of a depressive disorder. This is a commonly used cutoff ([@ref-18]; [@ref-22]), and was chosen for the THPP and THPP+ trials because of its high positive predictive value for the diagnosis of depressive disorder in the (non-Pakistan) literature ([@ref-31]). Evaluating the validity of the cutoff of 10 or above on the PHQ-9 was prespecified based on the trial design. We also examined the sensitivity and specificity of cutoffs ranging from five to 20 as an exploratory analysis. Since the same interviewer administered both the PHQ-9 and SCID, the assessors were not blinded to the results of the PHQ-9 when administering the SCID.

Statistical analysis
--------------------

In order to test the criterion-related validity and reliability of scores from the Urdu version of PHQ-9, we examined the psychometric properties of PHQ-9 using SCID as a gold standard, using the THPP and THPP+ screening dataset of 1,731 women. There was no missing data, as all items from the PHQ-9 and a diagnosis from the SCID were available on all women screened, and no index test or reference standard results were indeterminate. To verify the association between PHQ-9 and SCID, we assessed the criterion-related validity of PHQ-9 in Urdu in reference to the SCID by calculating sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) using cutoff values ranging from five to 20. Sensitivity and specificity of cutoffs were also visualized using a receiver operating characteristic (ROC) curve, from which was computed area under the curve (AUC). The internal reliability of the Urdu version of the PHQ-9 was assessed based on the value of the overall Cronbach's alpha. We also computed the Cronbach's alpha with each item deleted to further examine the inter-item consistency. Data were analyzed using Stata 15 (StataCorp, College Station TX, USA).

Results
=======

Participants
------------

A total of 1,731 women were screened for inclusion in the study. Overall, women had a mean (standard deviation \[SD\]) PHQ-9 score of 6.8 (6.3) \[range: 0--27\] in the screening sample. [Table 1](#table-1){ref-type="table"} displays demographic information that was additionally available on the 1,154 women who were invited to participate in the study based on the study design ([@ref-40]). These women had a mean (SD) PHQ-9 score of 8.7 (6.7) \[range: 0--27\] and mean (SD) age of 26.7 (4.5) years. To utilize the most data, we only report validity and reliability results for the full screened sample (*n* = 1, 731). If we used 10 or above as our cutoff for PHQ-9, approximately one-third of the women screened were considered to be at least moderately depressive. However, there were relatively fewer women (26%) who were diagnosed with depression based upon the results of SCID. The distribution of PHQ-9 scores and SCID results among all women screened are shown in [Table 2](#table-2){ref-type="table"}. In comparison with SCID, the moderate severity group (scoring from 10 to 14) had the largest inconsistency, since 112 (8.8%) women who were not depressed according to SCID had moderate depression severity according to PHQ-9 results.
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###### Baseline participant demographic characteristics, by PHQ-9 and SCID, *n* = 1, 154

Demographic characteristics are from a 1:1 depressed/non-depressed sample (as determined by PHQ-9 ≥ 10) of *n* = 1, 154 women.

![](peerj-06-5185-g002)

                                              PHQ-9 cutoff at 10   SCID current depressive episode   Total (*N* = 1,154)                       
  ------------------------------------------- -------------------- --------------------------------- --------------------- ------------------- -------------------
  **Age (in years)**                                                                                                                           
  Mean (SD)                                   26.4 (4.3)           27.0 (4.8)                        26.5 (4.3)            27.0 (4.8)          26.7 (4.5)
  Median (Q1, Q3)                             26.0 (23.0, 29.0)    27.0 (24.0, 30.0)                 26.0 (24.0, 30.0)     27.0 (23.0, 30.0)   26.0 (23.0, 30.0)
  Range                                       (18.0--40.0)         (18.0--45.0)                      (18.0--40.0)          (18.0--45.0)        (18.0--45.0)
  **Total \# of children in the household**                                                                                                    
  Mean (SD)                                   2.5 (2.6)            3.0 (2.7)                         2.6 (2.6)             3.1 (2.7)           2.8 (2.7)
  Median (Q1, Q3)                             2.0 (1.0, 4.0)       2.0 (1.0, 4.0)                    2.0 (1.0, 4.0)        2.0 (1.0, 4.0)      2.0 (1.0, 4.0)
  Range                                       (0.0--20.0)          (0.0--21.0)                       (0.0--20.0)           (0.0--21.0)         (0.0--21.0)
  **PHQ-9 total score**                                                                                                                        
  Mean (SD)                                   2.8 (2.5)            14.7 (3.7)                        4.7 (4.7)             15.1 (4.0)          8.7 (6.7)
  Median (Q1, Q3)                             3.0 (0.0, 4.0)       14.0 (12.0, 17.0)                 3.0 (1.0, 7.0)        15.0 (12.0, 18.0)   9.0 (3.0, 14.0)
  Range                                       (0.0--9.0)           (10.0--27.0)                      (0.0--25.0)           (2.0--27.0)         (0.0--27.0)
  **Grades woman has passed**                                                                                                                  
  None (0)                                    63 (10.8%)           107 (18.8%)                       83 (11.7%)            87 (19.7%)          170 (14.7%)
  Primary (1--5)                              87 (14.9%)           139 (24.4%)                       124 (17.4%)           102 (23.1%)         226 (19.6%)
  Middle (6--8)                               108 (18.5%)          107 (18.8%)                       129 (18.1%)           86 (19.5%)          215 (18.6%)
  Secondary (9--10)                           167 (28.6%)          126 (22.1%)                       191 (26.8%)           102 (23.1%)         293 (25.4%)
  Higher secondary (11--12)                   63 (10.8%)           46 (8.1%)                         74 (10.4%)            35 (7.9%)           109 (9.4%)
  Tertiary (\>12)                             96 (16.4%)           45 (7.9%)                         111 (15.6%)           30 (6.8%)           141 (12.2%)
  **Grades husband has passed**                                                                                                                
  None (0)                                    33 (5.7%)            55 (9.6%)                         42 (5.9%)             46 (10.4%)          88 (7.6%)
  Primary (1--5)                              45 (7.7%)            67 (11.8%)                        62 (8.7%)             50 (11.3%)          112 (9.7%)
  Middle (6--8)                               105 (18.0%)          137 (24.0%)                       132 (18.5%)           110 (24.9%)         242 (21.0%)
  Secondary (9--10)                           286 (49.0%)          243 (42.6%)                       347 (48.7%)           182 (41.2%)         529 (45.8%)
  Higher secondary (11--12)                   65 (11.1%)           47 (8.2%)                         73 (10.3%)            39 (8.8%)           112 (9.7%)
  Tertiary (\>12)                             50 (8.6%)            21 (3.7%)                         56 (7.9%)             15 (3.4%)           71 (6.2%)

**Notes.**

The baseline sample of *n* = 1, 154 is a subset of the screening sample of *n* = 1, 731.

Test results
------------

Criterion-related validity test results are reported in [Table 3](#table-3){ref-type="table"}. The sensitivity and specificity of PHQ-9 for a cutoff of 10 or more were 94.7% (95% CI \[92.2%--96.6%\]) and 88.9% (95% CI \[87%--90.6%\]), respectively. The PPV and NPV at this cutoff were 75.2% (95% CI \[71.4%--78.7%\]) and 97.9% (95% CI \[96.9%--98.7%\]). The tradeoff between sensitivity and specificity at each cutoff is also shown in [Fig. 1](#fig-1){ref-type="fig"}. The area under the curve (AUC) was 0.959 (95% CI \[0.950--0.968\]). According to the results in [Table 3](#table-3){ref-type="table"} and [Fig. 1](#fig-1){ref-type="fig"}, a cutoff of 10 or more seemed to be a good choice for using PHQ-9 as a depression screener, given high sensitivity and specificity. However, any cutoff between nine or more and 11 or more appeared to have good sensitivity and specificity, with the estimated sensitivity and specificity values above 85%. In their systematic review, [@ref-17] also found cutoffs in this range similar to the cutoff of 10 or more based on psychometric properties.

10.7717/peerj.5185/table-2

###### PHQ-9 Score cutoffs by SCID reference standard; screening sample, *n* = 1, 731.

![](peerj-06-5185-g003)

  PHQ-9 severity of depression   SCID depression status   Total (*N* = 1,731)   
  ------------------------------ ------------------------ --------------------- -------------
  Minimal, 0--4                  5 (1.1%)                 850 (66.6%)           855 (49.4%)
  Mild, 5--9                     19 (4.2%)                285 (22.3%)           304 (17.6%)
  Moderate, 10--14               202 (44.5%)              112 (8.8%)            314 (18.1%)
  Moderately severe, 15--19      160 (35.2%)              27 (2.1%)             187 (10.8%)
  Severe, 20+                    68 (15.0%)               3 (0.2%)              71 (4.1%)

We assessed internal reliability based on the overall standardized Cronbach's alpha for all items together and alpha when each item is deleted. The overall standardized Cronbach's alpha was 0.844, indicating a high internal consistency. The alpha if item deleted ranged from 0.809 to 0.842, which suggested that internal consistency remained unaffected even if one of the items was removed. Results are shown in [Table 4](#table-4){ref-type="table"}.

![Receiver operating characteristic (ROC) curve comparing different cutoffs of PHQ-9 score to the SCID reference standard; screening sample, *n* = 1, 731.\
Abbreviation: AUC, area under the curve. Bolded point indicates the cutoff of ≥10.](peerj-06-5185-g001){#fig-1}
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###### Psychometric properties of PHQ-9 at several cutoffs, with SCID as the reference standard; screening sample, *n* = 1,731.

![](peerj-06-5185-g004)

  PHQ-9 cutoffs   Sensitivity (95% CI)    Specificity (95% CI)    Positive predictive value (95% CI)   Negative predictive value (95% CI)
  --------------- ----------------------- ----------------------- ------------------------------------ ------------------------------------
  ≥5              98.9 (97.4--99.6)       66.6 (63.9--69.1)       51.3 (47.9--54.6)                    99.4 (98.6--99.8)
  ≥6              98.0 (96.3--99.1)       74.1 (71.6--76.5)       57.3 (53.8--60.9)                    99.1 (98.2--99.6)
  ≥7              97.4 (95.4--98.6)       80.9 (78.6--83.0)       64.4 (60.7--68.0)                    98.9 (98.0--99.4)
  ≥8              96.5 (94.3--98.0)       84.9 (82.8--86.8)       69.4 (65.7--73.0)                    98.5 (97.6--99.2)
  ≥9              95.8 (93.5--97.5)       87.9 (85.9--89.6)       73.7 (70.0--77.2)                    98.3 (97.4--99.0)
  **≥10**         **94.7 (92.2--96.6)**   **88.9 (87.0--90.6)**   **75.2 (71.4--78.7)**                **97.9 (96.9--98.7)**
  ≥11             89.0 (85.7--91.7)       91.9 (90.3--93.4)       79.7 (75.9--83.1)                    95.9 (94.6--97.0)
  ≥12             81.1 (77.1--84.6)       94.0 (92.6--95.3)       82.9 (79.1--86.3)                    93.3 (91.8--94.6)
  ≥13             70.0 (65.6--74.2)       95.5 (94.3--96.6)       84.8 (80.8--88.3)                    90.0 (88.2--91.5)
  ≥14             59.9 (55.2--64.5)       96.6 (95.4--97.5)       86.1 (81.8--89.7)                    87.1 (85.3--88.8)
  ≥15             50.2 (45.5--54.9)       97.7 (96.7--98.4)       88.4 (83.8--92.0)                    84.7 (82.7--86.5)
  ≥16             39.2 (34.7--43.9)       98.3 (97.4--98.9)       89.0 (83.8--93.0)                    82.0 (80.0--83.9)
  ≥17             33.9 (29.6--38.5)       98.7 (98.0--99.3)       90.6 (85.2--94.5)                    80.8 (78.7--82.7)
  ≥18             26.2 (22.2--30.5)       99.2 (98.6--99.6)       92.2 (86.2--96.2)                    79.1 (77.0--81.1)
  ≥19             19.6 (16.0--23.6)       99.5 (98.9--99.8)       92.7 (85.6--97.0)                    77.7 (75.6--79.7)
  ≥20             15.0 (11.8--18.6)       99.8 (99.3--100.0)      95.8 (88.1--99.1)                    76.7 (74.6--78.8)

**Notes.**

All numbers are percentages; using data from *n* = 1, 731 women screened for depression.

Bolded text highlights the psychometric properties at a cutoff of ≥10.
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###### Cronbach's alpha (internal reliability) results; screening sample, *n* = 1, 731.

![](peerj-06-5185-g005)

  PHQ-9 Items[^a^](#table-4fn1){ref-type="fn"}                          Cronbach's alpha if item deleted[^b^](#table-4fn2){ref-type="fn"}
  --------------------------------------------------------------------- -------------------------------------------------------------------
  1\. Feeling tired or having little energy                             0.828
  2\. Poor appetite or overeating                                       0.842
  3\. Trouble falling or staying asleep, or sleeping too much           0.836
  4\. Moving or speaking slowly                                         0.820
  5\. Trouble concentrating                                             0.836
  6\. Little interest or pleasure in doing things                       0.816
  7\. Feeling down, depressed, or hopeless                              0.809
  8\. Feeling bad about yourself                                        0.824
  9\. Thoughts that you would better off dead, or of hurting yourself   0.839
  **Overall Cronbach's alpha**                                          **0.844**

**Notes.**

Questions were asked in a different order than is standard.

Items were standardized.

Discussion
==========

Depressive disorders are highly prevalent and issues around screening and accurate diagnosis are still being debated ([@ref-17]), with some countries recommending screening only under certain circumstances, and other countries recommending against routine screening in primary care ([@ref-37]; [@ref-38]). In rural areas of LMICs where mental health services are limited, the benefits and drawbacks of screening for depressive disorder have to be weighed considering the health resources that do exist and the dangers associated with leaving populations undiagnosed. Valid and reliable screening tools to assist in detecting depressive disorder are much needed in low income settings where depressive disorders are more prevalent, such as in rural Pakistan, and where access to full diagnostic work-up is extremely limited. These valid and reliable screening tools are especially needed as more low-cost, effective community-based interventions are implemented and scaled up in these rural areas ([@ref-29]). While Urdu versions of several instruments for detecting depressive disorders have been validated in Pakistani settings, the Urdu version of the PHQ-9 has not been tested for criterion-related validity in a community setting in Pakistan ([@ref-2]; [@ref-9]).

Through piloting the PHQ-9 in Urdu, we found that it was easily understood by community-based pregnant women, who answered both somatic and psychological items with equal ease. Using a diagnostic interview for comparison, data from the full screening sample of 1,731 pregnant women showed the Urdu version of the PHQ-9 had good criterion-related validity, similar to that reported in other studies ([@ref-3]; [@ref-42]). The Urdu version PHQ-9 also had a high internal reliability (Cronbach's alpha = 0.844) in this sample. The internal reliability in the current study is comparable to what other studies report within varied populations with alpha value of 0.85--0.90 ([@ref-1]; [@ref-11]; [@ref-19]).

We note that for a cutoff of ≥10 the specificity is right in line with the pooled (from 36 studies) specificity obtained in [@ref-22], however, the sensitivity is well above the upper limit of the pooled 95% confidence interval reported. This could be because of the interviewer administered both the SCID and PHQ-9 in the current study or because the studies summarized in [@ref-22] do not include populations culturally similar to Pakistan. Also, the studies reported in [@ref-22] included mainly hospital or clinic samples, rather than a community-based population. The high value of the AUC (0.959) in this study demonstrates diagnostic accuracy which is in line with a number of studies ([@ref-11]; [@ref-14]; [@ref-19]).

The most reliable estimates (using a clinical interview rather than a screener) among antenatal women in rural Pakistan show a depression prevalence of 23--26% ([@ref-26]; [@ref-29]), in line with the estimate from our study based on SCID (26%). Linking results from the current study to this estimated prevalence, a cutoff of ≥10 for PHQ-9 (with sensitivity and specificity of 94.7% and 88.9%, respectively) in a population where 26% of pregnant women are depressed corresponds to approximately three out of four (75.2%) new cases identified by the PHQ-9 being true cases.

One of the limitations of our study was that the same research team administered PHQ-9 and SCID in a single phase design and were not blind to PHQ-9 scores of the study participants when they administered the SCID. This is a potential source of interviewer bias, since knowing the results of one test may influence the interviewer's assessment of the woman on the other test. However, the interviewers were not aware that the data being collected would contribute to a validation study. In addition, each interviewer administered the SCID to a wide range of PHQ-9 high and low scoring participants, thus minimizing any potential interviewer bias of not being blind to PHQ-9 scores.

Another limitation of and potential source of bias in this study is that these women were not asked for previous medical records or diagnosis of depression they may have had. Including women with a prior diagnosis of depressive disorder in our study could lead to a sample with increased severity and prevalence of depression, which may inflate the reported sensitivity of PHQ-9 in relation to the SCID ([@ref-36]). However, in this rural Pakistan setting medical histories and records are generally not kept or maintained and if available are not considered reliable. Additionally, given the lack of mental health services in this area, the probability of the women in this study area having had a previous diagnosis of depression is vanishingly small. Finally, the percentage of women (26%) in the screened sample who were diagnosed with depression based upon the results of the SCID is in line with the reported prevalence of depressive disorder during pregnancy of 23--26% from studies conducted in the same area of rural Pakistan ([@ref-26]; [@ref-29]).

Conclusions
===========

This study demonstrates that the Urdu version of the PHQ-9 has acceptable criterion-related validity and reliability for screening for depressive symptoms in Pakistan among community-based pregnant women; and when the recommended cut-off score of ≥10 is used it can also serve as an accurate screening tool for major depressive disorder.
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